NexgenRx (NXG) Insider Trading & Ownership C$0.28 +0.01 (+1.82%) (As of 05:22 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider Trades NexgenRx (CVE:NXG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.79%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)C$38,600.00Number OfInsiders Selling(Last 12 Months)0 Get NXG Insider Trade Alerts Want to know when executives and insiders are buying or selling NexgenRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NXG Insider Buying and Selling by Quarter Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. NexgenRx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2024Paul CrossettInsiderBuy20,000C$0.25C$5,000.005/24/2024Ronald Campbell LoucksDirectorBuy120,000C$0.28C$33,600.00 (Data available from 1/1/2013 forward) NXG Insider Trading Activity - Frequently Asked Questions Who is on NexgenRx's Insider Roster? The list of insiders at NexgenRx includes Kelly Tyler Ehler, Paul Crossett, and Ronald Campbell Loucks. Learn more on insiders at NXG. What percentage of NexgenRx stock is owned by insiders? 36.79% of NexgenRx stock is owned by insiders. Learn more on NXG's insider holdings. Which NexgenRx insiders have been buying company stock? The following insiders have purchased NXG shares in the last 24 months: Paul Crossett (C$5,000.00), and Ronald Campbell Loucks (C$33,600.00). How much insider buying is happening at NexgenRx? Insiders have purchased a total of 140,000 NXG shares in the last 24 months for a total of C$38,600.00 bought. NexgenRx Key ExecutivesMr. Ronald C. Loucks B.B.A. (Age 74)Founder, CEO, President & Director Compensation: $313.34kMr. Kelly Elher C.A.CPA, CA, CPA, Chief Financial OfficerMr. Andrew MunroeSenior Vice President of Pharma & Payor PartnersMr. Jason RobinsonSenior Vice President of AdministrationMs. Doreen HarveyLead Human ResourcesMr. Paul Anthony Bolger LL.B.M.B.A., Company SecretaryMr. Avik DebroyFinancial Controller More Insider Trading Tools from MarketBeat Related Companies Sernova Insider Ownership Theralase Technologies Insider Ownership Microbix Biosystems Insider Ownership KDA Group Insider Ownership Reliq Health Technologies Insider Ownership Aurora Spine Insider Ownership Decibel Cannabis Insider Ownership Nova Leap Health Insider Ownership DIAGNOS Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to Avoid This page (CVE:NXG) was last updated on 1/2/2025 by MarketBeat.com Staff From Our Partners3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Next Big Thing in AI: Musk’s Secret SupplierWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
